Table 2.
List of abbreviations
| ∙OH | Hydroxyl radical |
| 1O2 | Singlet oxygen |
| 2D | Two-dimensional |
| 4T1 | Mice breast tumor cell line |
| 22Rv1 | Human prostate cancer cell line |
| A431 | Human epidermoid carcinoma cell line |
| A549 | Human lung cancer cell line |
| Ag | Silver |
| AIA | Angiogenesis inhibiting agent |
| anti-PD-1 | Programmed cell death protein 1 antibody |
| anti-PD-L1 | Programmed cell death ligand 1 antibody |
| AQ4N | Banoxantrone dihydrochloride |
| AXT | Axitinib |
| ATP | Adenosine triphosphate |
| Au NP | Gold nanoparticle |
| B16F10 | Mouse melanoma cell line |
| BDOX | H2O2-sensitive doxorubicin prodrug |
| BPEI | Branched polyethylenimine |
| BSA | Bovine serum albumin |
| BCE | PEG-b-PHEMA crosslinked CPZ loaded BSA and CAT/GOx nanoclustered enzymes |
| C26 | Murine colon cancer cell line |
| C8161 | Human melanoma cell line |
| CT26 | Mouse colon cancer cell line |
| CA4 | Combretastatin A4 |
| CA4P | Combretastatin A4 disodium phosphate |
| CA4-NPs | Poly(L-glutamic acid)-CA4 conjugate nanoparticles |
| CDDP | Cisplatin |
| Ce6 | Chlorin e6 |
| CHC | α-cyano-4-hydroxycinnamate |
| CM | Cell membrane |
| CMSNs | Cancer cell membrane coated mesoporous silica nanoparticles |
| CPNP | Calcium phosphate nanoparticle |
| CPO | Chloroperoxidase |
| CPPO | Bis[2,4,5-trichloro-6-(pentyloxycarbonyl)phenyl]oxalate |
| CPT | Camptothecin |
| CST | Celastrol |
| CTX | Chlorotoxin |
| Cur | Curcumin |
| DDS | Drug delivery system |
| DCs | Dendritic cells |
| DMXAA | 5,6-dimethylxanthenone-4-acetic acid |
| DOX | Doxorubicin |
| ECs | Endothelial cells |
| EEPT | Enzyme-enhanced phototherapy |
| eM | Erythrocyte membrane |
| EMT-6 | Mouse mammary cancer cell line |
| EPR | Enhanced permeability and retention |
| FDA | Food and Drug Administration |
| FDMSNs | Ferrocene-functionalized dendritic mesoporous silica nanoparticles |
| GBM | Human glioblastoma cell line |
| GO | Graphene oxide |
| GOx | Glucose oxidase |
| GSH | Glutathione |
| H2O2 | Hydrogen peroxide |
| HA | Hyaluronic acid |
| HAP | Hypoxia-activated prodrug |
| HDL | High density lipoprotein |
| HFR | Heparin-folic acid-retinoic acid conjugate |
| HMON | Hollow mesoporous organosilica nanoparticle |
| H22 | Mouse hepatocellular carcinoma cell line |
| HepG2 | Human liver cancer cell line |
| HSC3 | Human oral squamous carcinoma cell line |
| HSP | Heat shock protein |
| HT-29 | Mouse colon tumor cell line |
| ICG | Indocyanine green |
| ICB | Immune checkpoint blockade |
| iNGR-NP | iNGR-modified PEG-PLGA nanoparticle |
| iNOS | NO synthase enzyme |
| IONP | Iron oxide nanoparticle |
| i.v. | Intravenous injection |
| LyP-1 | Phage-displayed cyclic peptide |
| LLC | Lewis lung carcinoma cell line |
| MCF-7 | Human breast cancer cell line |
| MCT1 | Monocarboxylate transporter 1 |
| MDA-MB-435 | Human breast cancer cell line |
| MDA-MB-231 | Human breast cancer cell line |
| MDR | Multidrug resistance |
| MDSCs | Myeloid-derived suppressor cells |
| Mg2Si | Magnesium silicide |
| MGP | GOx and MnCO coloaded poly(lactic-co-glycolic acid) nanoparticles |
| MIL-100 | Ferric ions contained metal organic framework |
| MGH | GOx loaded MIL-100 with polydopaminemodified hyaluronic acid coating |
| MMC | Mitomycin C |
| MMP | Matrix metalloproteinase |
| MnO2 | Manganese dioxide |
| M-NS | BSA-directed two-dimensional MnO2 nanosheet |
| MOF | Metal-organic framework |
| MOST | Multispectral optoacoustic tomography |
| MPN | Metal polyphenol network |
| MSN | Mesoporous silica nanoparticle |
| MTX | Methotrexate |
| nano-DOA | Nano-deoxygenation agent |
| NC | Nanocatalyst |
| NIR | Near-infrared |
| NM | Neutrophil membrane |
| NO | Nitric oxide |
| NP | Nanoparticle |
| NR | Nanoreactor |
| O2 | Oxygen |
| OCl- | Hypochlorite ion |
| OSCC | Oral squamous carcinoma cell line |
| PC-3 | Human prostate cancer cell line |
| Pdot | Polymer dot |
| PDT | Photodynamic therapy |
| PFC | Perfluorocarbon |
| PLA | Poly-L-arginine |
| PLL | poly (L-lysine) |
| PLGA | Polylactic-co-glycolic acid |
| PEG | Poly(ethylene glycol) |
| PEG-b-PHEMA | poly(ethylene glycol)-block-poly(2-hydroxyethyl methacrylate) |
| PLG-g-mPEG | Poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) |
| PPy | Polypyrrole |
| PTT | Photothermal therapy |
| PTX | Paclitaxel |
| PVP | Polyvinyl pyrrolidone |
| PZM | Porous Zr (IV)-based porphyrinic metal-organic framework |
| RA | Retinoic acid |
| RBC | Red blood cell |
| RGD | Arginine-glycine-aspartic acid |
| rMGB | Biomimetic hybrid nanozyme with a GOx/MnO2/BSA-Ce6 core and red blood cell membrane coating |
| ROS | Reactive oxygen species |
| SCC7 | Murine squamous cell carcinoma cell line |
| SGC7901 | Gastric cancer cell line |
| shVEGF | VEGF-targeted small hairpin RNA |
| SiO2 | Silicon dioxide |
| siRNA | Small interfering RNA |
| SMMC 7721 | Human liver tumor cell line |
| SR-B1 | Scavenger receptor type B-1 |
| SW620 | Human Caucasian colon adenocarcinoma cell line |
| TACE | Transarterial chemoembolization |
| TAF | Tumor angiogenesis factor |
| TCPP | Tetrakis (4-carboxyphenyl) porphyrin |
| THP | Tumor-homing peptide |
| TME | Tumor microenvironment |
| TPZ | Tirapazamine |
| UV | Ultraviolet |
| VDA | Vascular disrupting agent |
| VEGF | Vascular endothelial growth factor |
| U14 | Mouse cervical subcutaneous cancer cell line |
| U87 | Human glioblastoma cell line |
| U87MG | Human glioblastoma cell line |
| Vx2 | Rabbit carcinoma cell line |
| yCDglyTK | Fusion suicide gene |
| ZIF-8 | Zeolitic imidazolate framework-8 |
| αvβ3-Dxtl-PD NP | αvβ3-integrin targeted perfluorocarbon nanoparticle |